Andreas Pollreisz, MD, encourages taking a second look with OCT-A
EURETINA
At the EURETINA congress, Prof Pollreisz shared his contemporary approach to multimodal imaging in patients with diabetes.
EURETINA 2025: Why the current staging for diabetic eye disease is obsolete
During the EURETINA session, Stela Vujosevic, MD, PhD, FEBO, posed questions about the current staging for diabetic macular edema and diabetic retinopathy.
Harvey Uy, MD, DPBO, FVRSP, says AI brings a fifth dimension to retina care
At the EURETINA meeting, Professor Uy described the ways artificial intelligence can augment an existing imaging workflow.
EURETINA 2025: Peter Kiraly, PhD, helps young retinal specialists break into the vitreoretinal space
The EURETINA YOURS program prepares retina specialists for the EBO exam and helps them find training in the competitive subspecialty of vitreoretinal surgery.
Beacon Therapeutics announces positive topline data from DAWN and SKYLINE trials
Beacon Therapeutics shares promising phase 2 trial results for laru-zova, a gene therapy showing potential in treating X-linked retinitis pigmentosa.
Giuseppe Querques, MD, PhD, sheds light on two challenging pathophysiologies at EURETINA
Prof. Querques broke down perifoveal vascular anomalous complex (PVAC) and telangiectatic capillaries (TelCaps) for congress delegates.
EURETINA 2025: Sofia Androudi on retinal disorders mimicking inherited retinal diseases
Prof. Androudi said differential diagnoses are more important than ever in the era of cell and gene therapies.
Keynote speaker Maria Vittoria Cicinelli, MD, FEBO, says clinicians should rethink white spot syndrome
During her Ophthalmologica Lecture at the 2025 EURETINA Congress, Prof Cicinelli explained why it's time for a different approach to white spot syndromes.
Jean-Francois Korobelnik, MD, says surgeons under-utilize a key surgical tool
At the 2025 EURETINA Congress, Prof Korobelnik delivered the Gisbert Richard Lecture, focusing on removal of intra-ocular foreign bodies and mitigating ocular trauma.
EURETINA 2025: María Berrocal, MD, shares wisdom from her Kreissig Award Lecture
María Berrocal, MD, titled her Kreissig Award Lecture "Throwing away wisdom: How we abandon what works."
EURETINA 2025: Elon van Dijk on central serous chorioretinopathy
Don't miss the Women in Retina networking breakfast at EURETINA
Prof Tunde Peto and Prof Catherine Creuzot-Garcher will serve on an educational panel during the networking event.
EURETINA 2025: Timothy Lai discusses the SALWEEN 1-year data
EURETINA 2025: Aleksandra Rachitskaya and Danilo Iannetta on the Vit-Buckle Symposium
Aleksandra Rachitskaya, MD, FASRS, is a member of the Modern Retina editorial advisory board.
Ashvattha announces positive topline data for MGB for the treatment of DME and nAMD
EURETINA 2025: Marion Munk, Md, PhD, discusses the IntRIS symposium
The International Retinal Imaging Society (IntRIS) had a significant presence at this year's EURETINA Congress.
Ursula Schmidt-Erfurth, MD, discusses her keynote EURETINA Lecture
In her keynote address, Prof Schmidt-Erfurth focused on new artificial intelligence tools and their usage in addressing age-related macular degeneration.
EURETINA leadership welcome record-breaking number of attendees
This year's EURETINA meeting boasts a crowd of 10,000 attendees, including delegates, industry leaders, and young retina specialists.
Ramin Tadayoni Award 2025 winner announced at EURETINA Congress
Prithvi Ramtohul, MD, is a PhD candidate based in Marseille, France and previously completed a fellowship in Paris under Prof. Tadayoni.
PulseSight to highlight new data on the role of iron and transferrin in AMD at EURETINA 2025
BVI unveils new Virtuoso surgical platform
BVI launches Virtuoso, a groundbreaking dual-function surgical platform for cataract and vitreoretinal procedures, enhancing efficiency and control in surgery.
The Eye Care Network's clinical advisors will present at EURETINA
Where to find members of our editorial board at this year's European Society of Retina Specialists Congress.
EURETINA Innovation Spotlight kickstarts the 2025 Congress
Anat Loewenstein, MD, president of EURETINA, announces the EURETINA Innovation Spotlight (EIS) will return on September 3 this year.
AAVantgarde, Ocular Therapeutix, Oculis announce EURETINA presentations
Leading companies to unveil new research on retinal diseases at EURETINA 2025, showcasing innovative therapies and clinical trial results.
XLRP, RP, and wet AMD trial data slotted for presentation at EURETINA 2025
Upcoming EURETINA 2025 presentations from Clearside, ZEISS, and Ashvattha
Advancements in retinal therapies and technologies are scheduled to be showcased at EURETINA 2025 from Clearside, ZEISS, and Ashvattha Therapeutics.
Don't miss our editorial board at the 2025 EURETINA Congress
At the 2025 EURETINA Congress, keep an eye out for 11 editorial advisory board members from Modern Retina, Ophthalmology Times and Ophthalmology Times Europe.
EURETINA marks a milestone with 25th annual Congress
Retina specialists will celebrate the major anniversary this September in Paris, France.
ASRS 2025: Geographic atrophy on display
ASRS
A look at podium presentations on GA research at ASRS 2025.
Alcon presenting new retina tools, clinical data at ASRS
Notably, Alcon will be providing a demo of the UNIPEXY Gas Delivery System.